Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Breast Neoplasms 13Lung Neoplasms 10Uterine Cervical Neoplasms 9Neoplasms 8Colonic Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Prostatic Neoplasms 3Papillomavirus Infections 3Liver Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Patient Compliance 2Neoplasm Metastasis 2Hematologic Neoplasms 2Colorectal Cancer Screening 2Carcinoma, Intraductal, Noninfiltrating 2Tobacco Use 1Smoking 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Overweight 1Obesity 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Liver Diseases 1Hypertension 1Hepatitis C 1

Interventions

Sorafenib 5Blood Specimen Collection 4lenvatinib 3sintilimab 2pembrolizumab 2ledipasvir, sofosbuvir drug combination 2halofantrine 2camrelizumab 2atezolizumab 2Liver Transplantation 2Immunotherapy 2Control Groups 2Bevacizumab 2Antibodies 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1rubitecan 1repotrectinib 1pevonedistat 1ozanimod 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Patient Navigation × Clear all
NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

University of Texas Southwestern Medical Center

Phase NA Completed
1,800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡